Xenia Hotels & Resorts, Inc.
XHR NYSE Hotels & Motels Financials FY2016βFY2025
What Xenia Hotels & Resorts, Inc. does
No business description yet.
- Legal name
- Xenia Hotels & Resorts, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001628280-26-011060
0001616000
Revenue and margins
Xenia Hotels & Resorts, Inc. had $1.1B of revenue in fiscal 2025, up 3.8% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β2.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Xenia Hotels & Resorts, Inc. returned $121M to shareholders in fiscal 2025. The diluted share count fell 5.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Xenia Hotels & Resorts, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $517M | $305M | $165M | $78.2M | $140M |
| Debt incl. finance leases | $1.5B | $1.4B | $1.4B | $1.3B | $1.4B |
| Net debt / EBITDA | 14.3x | 4.6x | 5.4x | 5.8x | 5.4x |
| Debt / equity | 1.0x | 1.0x | 1.1x | 1.1x | 1.3x |
| Interest coverage | β0.7x | 1.3x | 1.1x | 1.1x | 1.2x |
| Total assets | $3.1B | $3.1B | $2.9B | $2.8B | $2.8B |
| Total liabilities | $1.6B | $1.6B | $1.6B | $1.6B | $1.6B |
| Shareholders' equity | $1.4B | $1.4B | $1.3B | $1.2B | $1.1B |
| Net debt (β = net cash) | $977M | $1.1B | $1.2B | $1.3B | $1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 6 / 8 | 4 / 8 | 1 / 8 | 5 / 8 | 7 / 8 | 5 / 8 | 6 / 8 | 7 / 8 |
| Accruals ratio | β5.0% | β3.8% | β1.9% | β5.9% | β2.7% | β6.0% | β4.3% | β6.0% | β5.1% | β4.0% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $950M | $945M | $1.1B | $1.1B | $370M | $616M | $998M | $1.0B | $1.0B | $1.1B |
| Gross profit | $357M | $342M | $368M | $376M | $18.2M | $170M | $325M | $322M | $309M | $330M |
| Operating income | $112M | $104M | $132M | $111M | β$242M | β$60.9M | $111M | $97.6M | $86.8M | $108M |
| Interest expense | $48.1M | $46.3M | $51.4M | $48.6M | $62.0M | $81.3M | $82.7M | $85.0M | $80.9M | $86.7M |
| Pretax income | $91.8M | $109M | $205M | $62.6M | β$183M | β$146M | $59.8M | $21.3M | $13.1M | $68.3M |
| Income tax | $5.1M | $7.8M | $6.0M | $5.4M | β$15.9M | $0.7M | $2.2M | $1.4M | β$3.7M | $1.4M |
| Net income | $85.9M | $98.9M | $194M | $55.4M | β$163M | β$144M | $55.9M | $19.1M | $16.1M | $63.1M |
| Net income to common | $85.9M | $98.3M | $193M | $54.9M | β$163M | β$144M | $55.7M | $18.9M | $15.8M | $62.6M |
| Diluted EPS | $0.79 | $0.92 | $1.75 | $0.49 | β$1.44 | β$1.26 | $0.49 | $0.17 | $0.15 | $0.64 |
| Diluted shares | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.10B | 0.10B |
| Cash flow | ||||||||||
| Cash from operations | $229M | $213M | $254M | $247M | β$77.7M | $40.8M | $187M | $198M | $164M | $177M |
| Depreciation and amortization | $152M | $153M | $158M | $155M | $147M | $129M | $133M | $132M | $129M | $131M |
| Stock-based compensation | $9.0M | $9.9M | $9.2M | $9.4M | $10.9M | $11.6M | $11.4M | $13.2M | $13.7M | $13.1M |
| Share buybacks | $74.0M | $4.1M | $0.0M | $0.0M | $2.3M | $0.0M | $28.2M | $133M | $15.9M | $120M |
| Dividends paid | $115M | $118M | $122M | $126M | $63.2M | $0.1M | $0.6M | $0.6M | $0.4M | $0.6M |
| Dividends and buybacks | $189M | $123M | $122M | $126M | $65.4M | $0.1M | $28.8M | $133M | $16.2M | $121M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $216M | $71.9M | $91.4M | $111M | $390M | $517M | $305M | $165M | $78.2M | $140M |
| Total debt | $1.1B | $1.3B | $1.2B | $1.3B | $1.4B | $1.5B | $1.4B | $1.4B | $1.3B | $1.4B |
| Finance lease liabilities | β | β | β | β | β | β | β | β | $2.0M | $7.6M |
| Goodwill | $42.1M | $39.8M | $34.4M | $25.0M | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M |
| Intangible assets | $34.8M | $28.2M | $27.2M | $4.0M | $1.6M | $0.6M | $0.2M | $0.0M | $0.0M | $0.0M |
| Total assets | $2.9B | $3.1B | $3.2B | $3.3B | $3.1B | $3.1B | $3.1B | $2.9B | $2.8B | $2.8B |
| Total liabilities | $1.2B | $1.5B | $1.3B | $1.5B | $1.5B | $1.6B | $1.6B | $1.6B | $1.6B | $1.6B |
| Shareholders' equity | $1.6B | $1.6B | $1.8B | $1.7B | $1.6B | $1.4B | $1.4B | $1.3B | $1.2B | $1.1B |
| Margins | ||||||||||
| Gross margin | 37.6% | 36.1% | 34.8% | 32.7% | 4.9% | 27.6% | 32.6% | 31.4% | 29.7% | 30.6% |
| Operating margin | 11.7% | 11.0% | 12.5% | 9.7% | β65.4% | β9.9% | 11.2% | 9.5% | 8.4% | 10.0% |
| EBITDA margin | 27.8% | 27.1% | 27.4% | 23.2% | β25.7% | 11.1% | 24.5% | 22.4% | 20.7% | 22.1% |
| Net margin | 9.0% | 10.5% | 18.3% | 4.8% | β44.2% | β23.3% | 5.6% | 1.9% | 1.6% | 5.8% |
| Returns | ||||||||||
| Return on capital | 4.2% | 3.4% | 4.4% | 3.5% | β7.5% | β2.0% | 4.2% | 3.6% | 3.5% | 4.4% |
| Return on equity | 5.3% | 6.1% | 11.3% | 3.1% | β9.9% | β9.6% | 3.9% | 1.4% | 1.3% | 5.3% |
| Return on assets | 3.0% | 3.3% | 6.2% | 1.7% | β5.2% | β4.7% | 1.8% | 0.6% | 0.6% | 2.2% |
| Return on tangible equity | 5.5% | 6.4% | 11.0% | 3.2% | β10.6% | β10.1% | 3.9% | 1.5% | 1.3% | 5.5% |
| Growth | ||||||||||
| Revenue growth | β | β0.5% | 11.9% | 8.6% | β67.8% | 66.6% | 61.9% | 2.8% | 1.3% | 3.8% |
| Net income growth | β | 15.2% | 95.9% | β71.4% | β394.8% | β | β | β65.8% | β15.7% | 290.8% |
| EPS growth | β | 16.5% | 90.2% | β72.0% | β393.9% | β | β | β65.3% | β11.8% | 326.7% |
| Share count change | β | β1.0% | 3.1% | 2.3% | 0.5% | 0.3% | 0.5% | β5.2% | β5.7% | β5.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.3x | 4.9x | 3.7x | 4.4x | β | 14.3x | 4.6x | 5.4x | 5.8x | 5.4x |
| Debt / equity | 0.7x | 0.8x | 0.6x | 0.7x | 0.9x | 1.0x | 1.0x | 1.1x | 1.1x | 1.3x |
| Interest coverage | 2.3x | 2.2x | 2.6x | 2.3x | β3.9x | β0.7x | 1.3x | 1.1x | 1.1x | 1.2x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.9% | 1.1% | 0.9% | 0.8% | 3.0% | 1.9% | 1.1% | 1.3% | 1.3% | 1.2% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 6.0 | 4.0 | 1.0 | 5.0 | 7.0 | 5.0 | 6.0 | 7.0 |
| Accruals ratio | β5.0% | β3.8% | β1.9% | β5.9% | β2.7% | β6.0% | β4.3% | β6.0% | β5.1% | β4.0% |
Source: SEC EDGAR XBRL filings (CIK 0001616000). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.